News
Watch this space for the latest News from Pharmora.
Current and future treatments for HIV/AIDS, Medical Information (3 of 3)
In this 3rd and final blog of the series, Josh describes the current management of HIV/AIDS, discusses the medicines in development, and provides an insight into the health inequality impacting this condition.
Early treatments, the Stigma and HAART, Medical Information (2 of 3)
In our previous blog, we looked at the initial discovery of HIV, the mechanisms of how it infects CD4 cells and the human cost of the virus in the 1980s. Here, we will discuss the first treatments to become available for HIV, their side effects, the stigma associated with the disease and what that meant for patient prognosis, and the introduction of Highly Active Antiretroviral Therapy (HAART).
Celebrating the 10th Annual Global Campaign for Patient Safety
The much-anticipated MedSafetyWeek - now in its tenth year - is here! This year’s theme, “We can all help make medicines safer,” highlights the collective role we play in ensuring medicine safety. By reporting suspected adverse reactions to medicines and vaccines, and...
Conversations With Industry Leaders : Dr Sheuli Porkess
Dr Jones was delighted to meet with Dr Sheuli Porkess, Director of Actaros Consultancy and President of the Faculty of Pharmaceutical Medicine to talk about some hot topics in our industry! Read on to hear their insights on AI and the challenges of encouraging diversity in our industry…
World Drug Safety Congress Europe 2025
Hear insights on the biggest safety congress this year, from our Chief Medical Officer Dr Stephanie Jones.
Hereditary Cancer Awareness Week: Understanding Risk, Empowering Families
Hereditary Cancer Awareness Week raises awareness of inherited cancer risks such as BRCA and Lynch syndrome. Learn how family history, genetic testing, and new research in population screening and polygenic risk scores are shaping the future of cancer prevention.
World Patient Safety Day 2025: Patient Safety from the Start
This year’s World Patient Safety Day highlights “Patient safety from the start: safe care for every newborn and child”. We support safer outcomes for children and vulnerable patients through rigorous data review, pregnancy precautions, and paediatric safety expertise. Read more.
From Powerhouse to Patient Care: Understanding Mitochondrial Disease
Mitochondria are often called the “powerhouses” of our cells, but when their DNA carries variants, families can face difficult and lifelong health challenges. We are marking World Mitochondrial Disease Week with this educational blog – read on to learn more.
AI, machine learning, and the first BioAI conference from Bionow
AI in biosciences has been a developing topic for discussion at many recent conferences, so it was time it got its own! Read on to learn more about the BioAI conference…
National Schizophrenia Awareness Day – July 25th
Schizophrenia is a commonly misunderstood mental health condition which 1 in 300 people have worldwide. It is important to spread awareness this National Schizophrenia Awareness Day so those who need support can access it. Read on to find out more.
My Time at Pharmora (so far)
Learn what it’s like to be a part of the team at Pharmora, as Rhandel describes his first year at our organisation.
Conversations with Industry Leaders: Dr Sue Lim 1 April 2025
By Dr Stephanie-Jayne Jones
On 1st April I caught up with Dr Sue Lim in the latest in my series of “Conversations with Leaders in our Industry”. Dr Lim is an experienced former FDA director and licensed physician with around 2 decades of global drug development experience.
Conversation with Industry Leaders: Professor Alan Boyd 11 April 2025
Continuing conversations with industry leaders, CMO Dr Jones interviews Professor Alan Boyd, ex President of the FPM. Some of you will know him as the former President of the Faculty of Pharmaceutical Medicine, some will know him as the entrepreneur who created @Boyds and others will know him as an engaging and expert mentor, dedicated to training and empowering the next generation of people working in the pharmaceutical industry.
Immunisation Masterclass (3) HPV Vaccination
As the third blog of the immunisation masterclass series is published on International HPV Awareness Day, Pharmora would like to take this opportunity to highlight the importance of HPV vaccination. Read this blog where we explore HPV and its associated risk, why you need an HPV vaccination, and debunk some common myths around the topic!
Understanding Gaucher Disease
Gaucher disease is a rare genetic disorder caused by a deficiency in the enzyme glucocerebrosidase, leading to a harmful buildup of fat in cells. This causes symptoms like enlarged organs, bone pain, and, in some cases, neurological impairment. Current treatments offer relief but come with limitations such as inconvenient infusions, side effects, and the inability to address neurological symptoms. Read on to discover the promising new developments bringing hope for this rare disease…
The MHRA’s Patient Involvement Strategy 2021-25
The MHRA launched the Patient Involvement Strategy 2021-2025. Now, in the final year of the strategy, what has been done for Patient Involvement, and what do the MHRA plan to do next? Read on to learn…
The EMA’s IRIS platform – what is it, and what does it mean for MAHs?
The EMA is transitioning all of the communications during the Marketing Authorisation process to its IRIS platform, read on to learn more about what this might mean for you.
Recent trends in the pharmaceutical industry: Patient-focus
In recent years, patient-centricity and patient-focus have been mentioned frequently in discussions about the future of the pharmaceutical industry. Pharmora have written a series of blogs to dissect and discuss this trend, read on to learn more…
Landscape of Sarcoma Treatments Development
Reflecting on the current landscape of oncological drug development, Pharmora would like to take this opportunity to raise awarenesses of rare cancers that need more attention. In this blog, we put a spotlight on Sarcoma, where we summarise what sarcoma cancer is, what is in development in the changing treatment landscape, and what could be done in the future.
Gastric and Oesophageal cancer: Causes and Treatment
Gastric (stomach) and Oesophageal cancer are among the least survivable cancers. Read on to learn about the differences in symptoms and in causes for these two cancers, and find out more about ongoing studies in this area…
Liver cancer: what do you need to know?
Celebrating the awareness week for Less Survivable Cancers, Pharmora is contributing to this campaign through a series of blogs. Liver cancer is classed as a ‘less survivable cancer’, but what is the past and the current landscape of treatment for this disease? Read on to find out…
The Windsor Framework
Urgent reminder of the Windsor Framework: the deadline is approaching! This is especially important for all medicines manufacturers with a current PLNI and PLGB licence. They need to urgently to cancel their PLNI to be automatically converted to a UK licence. Read on to find out more…
Immunisation Masterclass (2)
Continuing the Immunisation Masterclass series, our second blog revolves around the topic of oral vaccines. Read on to learn more about what oral vaccines are, what are they used for, their mechanism of action, and clinical trials of oral vaccines.
Introduction to HIV and patient outcomes – Medical Information, 1 of 3
In the first blog of this Master Class series, we will discuss the basics of HIV, including some of the history of its discovery and how it links to AIDS.
Bionow Oncology and & Precision Medicine Conference 10th -11th December
Join Us for the two-day Oncology & Precision Medicine Conference: explore the current oncology landscape on day one and the future of precision medicine on day two. Key topics on Day 1: early detection and diagnosis, the future and sustainability of cancer treatment, the state of the funding and regulatory landscape, and patient perspectives.
Unblinded Medical Review (UMR): How does it work in Pharmora?
In a follow up to the blog outlining what unblinded medical review (UMR) means and why it might be needed, this case study from one of the UMR team explains how Pharmora can support with UMR of clinical trial data.
Unblinded Medical Review (UMR): what is it and when is it needed?
In this blog we explain what UMR means and why the Sponsors of clinical trials for investigational medicinal products might need it.
How can Pharmora help to commercialise your product? (Part 1)
Pharmora can help bring more medicines to the patients who benefit from them, helping the patient and the manufacturer. Read more to find out how!
In this first blog of two the CMO describes the context of our work
The importance of reporting adverse events
Have you ever experienced an adverse event after taking a medication? Did you tell a healthcare professional about it? Would you know how to report it? Read on to find out why it is important to report!
What is the summary of product characteristics and how does it help me?
The theme for #medsafetyweek2024 is “The importance of using medicines correctly to prevent side effects”. In order to do this we need some information on correct use. Where do we find this? Read on to find out!
Faculty of Pharmaceutical Medicine Annual Symposium
On Thursday the 21st of November 2024, the Faculty of Pharmaceutical Medicine is holding their Annual Symposium in London. The event will be held at the Royal Society.
‘Immediate Communication’
Clinical Development Scientist – Senior Director
Breast Cancer Blog (2) – Recent Advances in Breast Cancer
Following our recent blogs highlighting the necessity to raise awareness of breast cancer, Pharmora would like to take this opportunity dive in the recent advances in breast cancer detection and therapies, to understand how the pharmaceutical industry is joining the fight against breast cancer.
Breast Cancer Awareness Month: Let’s Make a Difference!
Breast Cancer Awareness Month is a time to emphasize the importance of early detection, education, and community involvement in the fight against breast cancer. Read on to find out about the importance of breast cancer awareness.
Pharmora’s Sparkling Prize Draw
At our most recent conference, Pharmora once again held our Prize Draw for a bottle of fizz! And the winner was …
Pharmora at World Drug Safety Congress – Europe
Hear from Pharmora Limited’s Stephanie Jones and Ian Pinches as they discuss the benefits of attending the World Drug Safety Congress 2024 and what they do at Pharmora Limited
World Mental Health Day Awareness 2024
10th of October 2024 was World Mental Health Awareness Day. Read on to learn more about what this means for us at Pharmora, and how we can all help to Prioritise Mental Health in the Workplace…
Pharmora RMP Masterclass (3) Updates to EMA guidance on RMMs
On 11th September there was an EMA webinar to launch the updates to GVP Module XVI on Risk Minimisation Measures and its Addendum II. Read on for a summary of the key updates…
Pharmora RMP Masterclass (2): RMP Development Process -TOP TIPS
In this blog our CMO, Dr Stephanie Jones, provides detailed guidance on how to save time and effort and produce high quality risk management plans. Read on to find out more!
Pharmora RMP Masterclass (1): History of RMP legislation in different regions.
The Risk Management Plan (RMP) is a detailed description of the activities and interventions designed to identify, characterise, prevent or minimise risks relating to medicines. Read on to find out how this important document differs across the world.
